Sevoflurane downregulates interleukin-6 and interleukin-8 levels in patients after cardiopulmonary bypass surgery: A meta-analysis

Genetics and Molecular Research

Volumn 14, Issue 4, 2015, Pages 19016-19027

  Yu, Q B ^a   Li, H M ^a   Li, L L ^a   Wang, S Y ^a   Wu, Y B ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Cardiopulmonary bypass; Interleukin 6; Interleukin 8; Meta analysis; Sevoflurane

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; SEVOFLURANE; ANTIINFLAMMATORY AGENT; ETHER DERIVATIVE; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN;

ARTICLE; CARDIOPULMONARY BYPASS; CASE CONTROL STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; HUMAN; META ANALYSIS (TOPIC); PROTEIN BLOOD LEVEL; BLOOD; HEART DISEASES; META ANALYSIS; PREMEDICATION;

ANTI-INFLAMMATORY AGENTS; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; DOWN-REGULATION; HEART DISEASES; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; METHYL ETHERS; PREMEDICATION;

EID: 84952684487     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.December.29.9     Document Type: Article

References (40)

1. Aguado D, Abreu M, Benito J, Garcia-Fernandez J, et al. (2014). Amitriptyline, minocycline and maropitant reduce the sevoflurane minimum alveolar concentration and potentiate remifentanil but do not prevent acute opioid tolerance and hyperalgesia in the rat: a prospective, randomised laboratory study. Eur. J. Anaesthesiol. 32: 248-254.
2. Anzai M, Iijima N, Higo S, Takumi K, et al. (2013). Direct and specific effect of sevoflurane anesthesia on rat Per2 expression in the suprachiasmatic nucleus. PLoS One 8: e59454.
3. Bouwman RA, Musters RJ, van Beek-Harmsen BJ, de Lange JJ, et al. (2007). Sevoflurane-induced cardioprotection depends on PKC-alpha activation via production of reactive oxygen species. Br. J. Anaesth. 99: 639-645.
4. Cho EJ, Yoon JH, Hong SJ, Lee SH, et al. (2009). The effects of sevoflurane on systemic and pulmonary inflammatory responses after cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 23: 639-645.
5. Deegan CA, Murray D, Doran P, Moriarty DC, et al. (2010). Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg. Anesth. Pain. Med. 35: 490-495.
6. Dong P, Zhao J, Zhang Y, Dong J, et al. (2014). Aging causes exacerbated ischemic brain injury and failure of sevoflurane post-conditioning: role of B-cell lymphoma-2. Neuroscience 275: 2-11.
7. Egger M, Davey Smith G, Schneider M and Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
8. Gao CJ, Li B, Wang HX, Lv XM, et al. (2012). Effects of sevoflurane pretreatment on inflammatory response in patients undergoing cardiac valve replacement with cardiopulmonary bypass. Chin. J. Anesthesiol. 2: 1081-1084.
9. Grommes J and Soehnlein O (2011). Contribution of neutrophils to acute lung injury. Mol. Med. 17: 293-307.
10. Jackson D, White IR and Riley RD (2012). Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat. Med. 31: 3805-3820.
11. Kortekaas KA, van der Baan A, Aarts LP, Palmen M, et al. (2014). Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repair. Br. J. Anaesth. 112: 1005-1014.
12. Kristen AV, Ackermann K, Buss S, Lehmann L, et al. (2013). Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion. Cardiovasc. Pathol. 22: 280-286.
13. Lee IT and Yang CM (2012). Role of NADPH oxidase/ROS in pro-inflammatory mediators-induced airway and pulmonary diseases. Biochem. Pharmacol. 84: 581-590.
14. Lenski M and Scherer MA (2014). The significance of interleukin-6 and lactate in the synovial fluid for diagnosing native septic arthritis. Acta. Orthop. Belg. 80: 18-25.
15. Li H, Zhou C, Chen D, Fang N, et al. (2013). Failure to protect against myocardial ischemia-reperfusion injury with sevoflurane postconditioning in old rats in vivo. Acta. Anaesthesiol. Scand. 57: 1024-1031.
16. Ma J, Fang C, Wang RM, Kang F, et al. (2009). Effect of sevoflurane preconditioning on protecting lung injury in patients undergoing cardiac surgery with cardiopulmonary bypass. Shandong Med. J. 91-93.
17. Mao QQ, Zou J and Zhang ZJ (2012). Effect of sevoflurane preconditioning on inflammatory response in 40 patients undergoing cardiac surgery with cardiopulmonary bypass. Chongqing Med. 41: 1975-1976.
18. Muller-Redetzky HC, Suttorp N and Witzenrath M (2014). Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives. Cell Tissue Res. 355: 657-673.
19. Nader ND, Li CM, Khadra WZ, Reedy R, et al. (2004). Anesthetic myocardial protection with sevoflurane. J. Cardiothorac. Vasc. Anesth. 18: 269-274.
20. Nader ND, Karamanoukian HL, Reedy RL, Salehpour F, et al. (2006). Inclusion of sevoflurane in cardioplegia reduces neutrophil activity during cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 20: 57-62.
21. Ogurlu M, Sari S, Kucuk M, Bakis M, et al. (2014). Comparison of the effect of propofol and sevoflurane anaesthesia on acute and chronic postoperative pain after hysterectomy. Anaesth. Intensive Care 42: 365-370.
22. Ong SB, Samangouei P, Kalkhoran SB and Hausenloy DJ (2015). The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury. J. Mol. Cell. Cardiol. 78: 23-34.
23. Onishi A, Miyamae M, Kaneda K, Kotani J, et al. (2012). Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A. Eur. J. Pharmacol. 675: 40-46.
24. Orriach JL, Aliaga MR, Ortega MG, Navarro MR, et al. (2013). Sevoflurane in intraoperative and postoperative cardiac surgery patients. Our experience in intensive care unit with sevoflurane sedation. Curr. Pharm. Des. 19: 3996-4002.
25. Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680.
26. Schmid E, Krajewski S, Bachmann D, Kurz J, et al. (2012). The volatile anesthetic sevoflurane inhibits activation of neutrophil granulocytes during simulated extracorporeal circulation. Int. Immunopharmacol. 14: 202-208.
27. Seki H, Fukunaga K, Arita M, Arai H, et al. (2010). The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J. Immunol. 184: 836-843.
28. Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25: 603-605.
29. Sunaga N, Kaira K, Tomizawa Y, Shimizu K, et al. (2014). Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma. Br. J. Cancer 110: 2047-2053.
30. Wang YW, Yu WL, Xue YL, Weng YQ, et al. (2013). Effects of sevoflurane wash-in during cardiopulmonary bypass on inflammatory responses in patients undergoing coronary artery bypass grafting. Chin. J. Anesthesiol. 33: 1185-1187.
31. Watanabe K, Iwahara C, Nakayama H, Iwabuchi K, et al. (2013). Sevoflurane suppresses tumour necrosis factor-alpha-induced inflammatory responses in small airway epithelial cells after anoxia/reoxygenation. Br. J. Anaesth. 110: 637-645.
32. Winterhalter M, Brandl K, Rahe-Meyer N, Osthaus A, et al. (2008). Endocrine stress response and inflammatory activation during CABG surgery. A randomized trial comparing remifentanil infusion to intermittent fentanyl. Eur. J. Anaesthesiol. 25: 326-335.
33. Xu B, Gao X, Xu J, Lei S, et al. (2011). Ischemic postconditioning attenuates lung reperfusion injury and reduces systemic proinflammatory cytokine release via heme oxygenase 1. J. Surg. Res. 166: e157-164.
34. Yin J, Wang SL and Liu XB (2014). The effects of general anaesthesia on memory in children: a comparison between propofol and sevoflurane. Anaesthesia 69: 118-123.
35. Zarogoulidis P, Katsikogianni F, Tsiouda T, Sakkas A, et al. (2014). Interleukin-8 and interleukin-17 for cancer. Cancer Invest. 32: 197-205.
36. Zhang J, Niu J and Yang J (2014). Interleukin-6, interleukin-8 and interleukin-10 in estimating the severity of acute pancreatitis: an updated meta-analysis. Hepatogastroenterology 61: 215-220.
37. Zhang XL, Wang Q, Zhou HY, Peng QM, et al. (2007). Effect of sevoflurane preconditioning on inflammatory response in patients undergoing cardiac surgery with cardiopulmonary bypass. Chin. J. Anesth. 27: 427-430.
38. Zhao J, Wang F, Zhang Y, Jiao L, et al. (2013). Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibition. Circulation 128: S121-S129.
39. Zhou SP, Liao WT, Yang LK and Sun L (2013). Effects of sevoflurane pretreatment on renal Src and FAK expression in diabetic rats after renal ischemia/reperfusion injury. Mol. Cell. Biochem. 384: 203-211.
40. Zintzaras E and Ioannidis JP (2005). HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21: 3672-3673.